RIL
LRMR icon

Rothschild Investment LLC’s Larimar Therapeutics LRMR Stock Holding History

Rothschild Investment LLC’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23K Buy
732
+445
+155% +$1.77K ﹤0.01% 2710
2026
Q1 		$1.29K Buy
287
+163
+131% +$652 ﹤0.01% 2761
2025
Q4 		$472 Buy
124
+14
+13% +$54 ﹤0.01% 2938
2025
Q3 		$355 Hold
110
– – ﹤0.01% 2903
2025
Q2 		$318 Buy
110
+75
+214% +$174 ﹤0.01% 2849
2025
Q1 		$75 Hold
35
– – ﹤0.01% 2987
2024
Q4 		$135 Buy
35
+20
+133% +$132 ﹤0.01% 2865
2024
Q3 		$98 Hold
15
– – ﹤0.01% 2853
2024
Q2 		$109 Buy
+15
New +$115 ﹤0.01% 2715

Other funds holding LRMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
NLP
Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return

Rothschild Investment LLC's LRMR Position: Q2 2026 in Review

Rothschild Investment LLC increased its Larimar Therapeutics (LRMR) stake by 155% in Q2 2026, buying an estimated $1.77K and bringing the position to 732 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #2710.

Rothschild Investment LLC first reported a position in LRMR in Q2 2024 and has held it in 9 quarters since. 46 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Rothschild Investment LLC held 732 shares of Larimar Therapeutics worth $2.23K as of Q2 2026.
  • Rothschild Investment LLC bought 445 Larimar Therapeutics shares in Q2 2026, an estimated $1.77K.
  • Larimar Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2710 holding.
  • Rothschild Investment LLC first reported a position in Larimar Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 46 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.